Exosomes Exploit the Virus Entry Machinery and Pathway To Transmit Alpha Interferon-Induced Antiviral Activity

Area of Science:

• Virology
• Cell Biology
• Immunology

Background:

• Alpha interferon (IFN-α) induces antiviral activity against hepatitis B virus (HBV) transfer via exosomes from liver nonparenchymal cells (LNPCs) to hepatocytes.
• The precise mechanisms of exosome entry and cargo release for IFN-α-induced antiviral activity remain largely unknown.

Purpose of the Study:

• To elucidate the entry machinery and pathway of macrophage-derived exosomes carrying IFN-α-induced anti-HBV activity into hepatocytes.
• To investigate the role of T cell immunoglobulin and mucin receptor 1 (TIM-1) in exosome entry.
• To understand the endocytic routes and intracellular events facilitating exosome-mediated antiviral cargo transfer.

Main Methods:

• Investigated exosome entry into hepatocytes using TIM-1 as a receptor.
• Analyzed the involvement of clathrin-mediated endocytosis (CME) and macropinocytosis in exosome uptake.
• Examined the role of lysobisphosphatidic acid (LBPA) in exosome fusion and cargo release within late endosomes/multivesicular bodies (LEs/MVBs).

Main Results:

• Macrophage exosomes utilize T cell immunoglobulin and mucin receptor 1 (TIM-1), a hepatitis A virus (HAV) receptor, to enter hepatocytes.
• Exosome entry and anti-HBV activity transfer are facilitated by a combination of CME and macropinocytosis.
• Lysobisphosphatidic acid (LBPA) promotes exosome membrane fusion and cargo uncoating within LEs/MVBs, similar to viral entry mechanisms.

Conclusions:

• Exosome-mediated transfer of IFN-α-induced anti-HBV activity shares similarities with viral entry pathways.
• Macrophage exosomes employ a distinct mechanism involving TIM-1 for hepatocyte entry.
• Understanding these exosome entry mechanisms can inform the development of exosome-based antiviral therapies.